Rabat - Five Moroccan hospital have started integrating Sophia Genetics’ artificial intelligence programs into their clinics to aid the identification of diseases causing mutations in patients’ genomic profiles.
Rabat – Five Moroccan hospital have started integrating Sophia Genetics’ artificial intelligence programs into their clinics to aid the identification of diseases causing mutations in patients’ genomic profiles.
The five Moroccan hospitals were revealed by Sophia Genetics, a global leader in data-driven medicine, during the 2017 Annual Meeting of the American College of Medical Genetics and Genomics (ACMG) in Phoenix, on March 24.
The Moroccan medical institutions that have incorporated Sophia Genetics into their medical plan are: Casablanca’s PHarmaProcess and Rabat’s ImmCell, Al Azhar Oncology Center, Riad Biology Center, and Oudayas’ Medical Analysis Laboratory.
The company has also established a center in Cape Town in South Africa and another in Douala in Cameroon.
The hospitals that have adopted Sophia Genetics’s AI have become part of a larger network of 260 hospitals in 46 countries that share biomedical findings across the world to advance in patients’ diagnostics and care.
Sophia will also aid African hospitals in cancer research. Breast cancer has been described as a “serial killer” in Africa, with over 60% of African women afflicted. And according to an earlier research on breast cancer by the International Prevention Research Institute, an earlier diagnosis of breast tumors could increase life expectancy by 30%.
“Since inception, our vision has been to develop innovative technological solutions that analyze patients’ genomic profiles to offer better diagnosis and care to the greatest number of patients, wherever they live. Today, I am very proud that SOPHIA is triggering a technological leapfrog movement in healthcare across Africa, ” said Sophia Genetics’ CEO and co-founder, Jurgi Camblong.
Hicham Mansour, Geneticist at the University of Mohamed I Genetic Department in the Al Azhar Oncology Center, added that “using Sophia allows us to analyze genomic data quickly and with great confidence, to better diagnose and follow up with our patients.”
Jurgi Camblong concluded that after many countries in Europe, Canada, Australia, Russia, and Latin America, the integration of Sophia in Africa is “perhaps the strongest evidence that the democratization of Data-Driven Medicine is changing lives across the globe.”